TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
B/P-Pharma AB
Closing information (x1000 EUR)
Closing information | 2023/04 | 2022/04 | 2021/04 |
Turnover | 1,148 | 1,156 | |
Financial expenses | 0 | 0 | |
Earnings before taxes | 31 | 16 | |
EBITDA | 32 | 18 | |
Total assets | 455 | 469 | |
Current assets | 453 | 466 | |
Current liabilities | 127 | 161 | |
Equity capital | 306 | 286 | |
- share capital | 5 | 5 | |
Employees (average) | 3 | 3 | 3 |
Financial ratios
Fiscal year | 2023/04 | 2022/04 | 2021/04 |
Solvency | 67.3% | 61.0% | |
Turnover per employee | 383 | 385 | |
Profit as a percentage of turnover | 2.7% | 1.4% | |
Return on assets (ROA) | 6.8% | 3.4% | |
Current ratio | 356.7% | 289.4% | |
Return on equity (ROE) | 10.1% | 5.6% | |
Change turnover | 10 | 16 | |
Change turnover % | 7% | 1% | 1% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/04 | 2022/04 | 2021/04 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.